These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16547553)

  • 1. The value of accurate analytics in the management of cardiovascular disease!
    Delport R
    Cardiovasc J S Afr; 2006; 17(1):3-5. PubMed ID: 16547553
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
    Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
    Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Journey through cholesteryl ester transfer protein inhibition: from bench to bedside.
    Karalis I; Rensen PC; Jukema JW
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):360-6. PubMed ID: 23674310
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid lowering: statins and the future.
    Shepherd J
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i46-7; discussion i50. PubMed ID: 10956323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypercholesteremia].
    Leiss O
    Dtsch Med Wochenschr; 2001 Jun; 126(23):704-5. PubMed ID: 11441669
    [No Abstract]   [Full Text] [Related]  

  • 7. The surprising AIM-HIGH results are not surprising when viewed through a particle lens.
    Otvos JD
    J Clin Lipidol; 2011; 5(5):368-70. PubMed ID: 21981836
    [No Abstract]   [Full Text] [Related]  

  • 8. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up with HDL, the "good" cholesterol. Guidelines mainly target LDL cholesterol, but HDL matters, too.
    Harv Womens Health Watch; 2008 Jun; 15(10):2-3. PubMed ID: 18853517
    [No Abstract]   [Full Text] [Related]  

  • 10. [HDL-cholesterol: role of its dosage in the assessment of cardiovascular risk].
    Guinchard-Foulon E; Rodriguez-Lafrasse C; Rousson R
    Ann Biol Clin (Paris); 2003; 61(5):549-56. PubMed ID: 14671752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct LDL-cholesterol measurement: not ready for the prime time?
    Lippi G; Montagnana M; Guidi GC
    Int J Cardiol; 2010 Nov; 145(1):86-7. PubMed ID: 19477028
    [No Abstract]   [Full Text] [Related]  

  • 13. The concept of precision extended to the atherogenic index of plasma.
    Holmes DT; Frohlich J; Buhr KA
    Clin Biochem; 2008 May; 41(7-8):631-5. PubMed ID: 18280809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All at sea: new lipid-lowering drug trials continue to disappoint.
    Wierzbicki AS
    Int J Clin Pract; 2013 Jul; 67(7):595-8. PubMed ID: 23758438
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is the future for niacin after the AIM-HIGH study?].
    Cybulska B; Kłosiewicz Latoszek L
    Kardiol Pol; 2012; 70(3):315-6. PubMed ID: 22430425
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease.
    Hansen AS; Marckmann P; Dragsted LO; Finné Nielsen IL; Nielsen SE; Grønbaek M
    Eur J Clin Nutr; 2005 Mar; 59(3):449-55. PubMed ID: 15674304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register.
    Eriksson M; Zethelius B; Eeg-Olofsson K; Nilsson PM; Gudbjörnsdottir S; Cederholm J; Eliasson B
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):97-105. PubMed ID: 21354969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methods for primary screening and laboratory diagnosis of dyslipidemia. January 2000 Guidelines. Agence Nationale D'accréditation Et D'évaluation En Santé].
    Agence Nationale D'accréditation Et D'évaluation En Santé (ANAES)
    J Mal Vasc; 2002 Oct; 27(4):226-30. PubMed ID: 12457129
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the high-density lipoprotein (HDL) particle in atherogenesis and potential methods to increase HDL concentrations].
    Birjmohun RS; van der Steeg WA; Stroes ES; Kastelein JJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2245-50. PubMed ID: 17076358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.